Laryngospasm in amyotrophic lateral sclerosis

Introduction Laryngospasm is an involuntary, sustained closure of sphincter musculature that leads to an unpleasant subjective experience of dyspnea and choking. It is an underreported symptom in amyotrophic lateral sclerosis (ALS). In this study we aimed to better characterize the prevalence and cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Muscle & nerve 2022-04, Vol.65 (4), p.400-404
Hauptverfasser: Gotesman, Ryan D., Lalonde, Emilie, McKim, Douglas A., Bourque, Pierre R., Warman‐Chardon, Jodi, Zwicker, Jocelyn, Breiner, Ari
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 404
container_issue 4
container_start_page 400
container_title Muscle & nerve
container_volume 65
creator Gotesman, Ryan D.
Lalonde, Emilie
McKim, Douglas A.
Bourque, Pierre R.
Warman‐Chardon, Jodi
Zwicker, Jocelyn
Breiner, Ari
description Introduction Laryngospasm is an involuntary, sustained closure of sphincter musculature that leads to an unpleasant subjective experience of dyspnea and choking. It is an underreported symptom in amyotrophic lateral sclerosis (ALS). In this study we aimed to better characterize the prevalence and clinical characteristics of laryngospasm in ALS patients. Methods The medical records of 571 patients with ALS followed between 2008 and 2018 were searched for evidence of laryngospasm. A total of 23 patients with laryngospasm were identified and the data related to patient and laryngospasm characteristics were extracted. Results Laryngospasm was reported in 4% of ALS patients. Females comprised 57% of patients and their mean age was 63.4 years. Laryngospasm frequently manifested in patients with moderate bulbar dysfunction and seemed independent of respiratory function. Among laryngospasm patients, 26% were cigarette smokers and 13% had a history of gastroesophageal reflux. The most common reported trigger was excessive saliva irritating the vocal cords (35%) followed by eating a meal (17%). There was significant variation in laryngospasm frequency (up to 5 per hour) and duration (seconds to minutes). Most patients could not identify an effective coping mechanism, although 13% reported that drinking water was effective. Discussion Despite its low prevalence in ALS, laryngospasm should be included in the symptom inquiry. The present findings may improve patient care through increased recognition of the clinical features of laryngospasm in ALS patients, identifying a link between laryngospasm and moderate bulbar dysfunction, and highlighting trigger avoidance as a management strategy. Additional research is required to understand the pathophysiology and optimal treatment. See Editorial on pages 367‐368 in this issue.
doi_str_mv 10.1002/mus.27466
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2601979388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2601979388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4196-c8b3dc914692a1ccbe9132d9feb67f78f842e4a5a4bf4d7da65b7bac9fb7eb023</originalsourceid><addsrcrecordid>eNp10E1LwzAcx_EgipvTg29ACl700C1p0jwcZfgEEw868BaSNNWOpq1Ji-zdm9HpQfCUy4cv-f8AOEdwjiDMFm4I84wRSg_AFEHBUpILfgimEBGeUizeJuAkhA2EEHHKjsEEE44YZGIK0pXy2-a9DZ0KLqmaRLlt2_u2-6hMUqveelUnwdTWt6EKp-CoVHWwZ_t3BtZ3t6_Lh3T1fP-4vFmlhiBBU8M1LoxAhIpMIWO0FQhnhSitpqxkvOQks0TliuiSFKxQNNdMKyNKzayGGZ6Bq7Hb-fZzsKGXrgrG1rVqbDsEmVGIBBOY80gv_9BNO_gm_i4qLASFmOdRXY_KxDuCt6XsfOXi6RJBudtQul12t2G0F_vioJ0tfuXPaBEsRvBV1Xb7f0k-rV_G5DdonXtT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2639960385</pqid></control><display><type>article</type><title>Laryngospasm in amyotrophic lateral sclerosis</title><source>Wiley Online Library - AutoHoldings Journals</source><creator>Gotesman, Ryan D. ; Lalonde, Emilie ; McKim, Douglas A. ; Bourque, Pierre R. ; Warman‐Chardon, Jodi ; Zwicker, Jocelyn ; Breiner, Ari</creator><creatorcontrib>Gotesman, Ryan D. ; Lalonde, Emilie ; McKim, Douglas A. ; Bourque, Pierre R. ; Warman‐Chardon, Jodi ; Zwicker, Jocelyn ; Breiner, Ari</creatorcontrib><description>Introduction Laryngospasm is an involuntary, sustained closure of sphincter musculature that leads to an unpleasant subjective experience of dyspnea and choking. It is an underreported symptom in amyotrophic lateral sclerosis (ALS). In this study we aimed to better characterize the prevalence and clinical characteristics of laryngospasm in ALS patients. Methods The medical records of 571 patients with ALS followed between 2008 and 2018 were searched for evidence of laryngospasm. A total of 23 patients with laryngospasm were identified and the data related to patient and laryngospasm characteristics were extracted. Results Laryngospasm was reported in 4% of ALS patients. Females comprised 57% of patients and their mean age was 63.4 years. Laryngospasm frequently manifested in patients with moderate bulbar dysfunction and seemed independent of respiratory function. Among laryngospasm patients, 26% were cigarette smokers and 13% had a history of gastroesophageal reflux. The most common reported trigger was excessive saliva irritating the vocal cords (35%) followed by eating a meal (17%). There was significant variation in laryngospasm frequency (up to 5 per hour) and duration (seconds to minutes). Most patients could not identify an effective coping mechanism, although 13% reported that drinking water was effective. Discussion Despite its low prevalence in ALS, laryngospasm should be included in the symptom inquiry. The present findings may improve patient care through increased recognition of the clinical features of laryngospasm in ALS patients, identifying a link between laryngospasm and moderate bulbar dysfunction, and highlighting trigger avoidance as a management strategy. Additional research is required to understand the pathophysiology and optimal treatment. See Editorial on pages 367‐368 in this issue.</description><identifier>ISSN: 0148-639X</identifier><identifier>EISSN: 1097-4598</identifier><identifier>DOI: 10.1002/mus.27466</identifier><identifier>PMID: 34817079</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>ALS ; Amyotrophic lateral sclerosis ; bulbar dysfunction ; case series ; Cigarette smoking ; clinical management ; Drinking water ; Dyspnea ; Frequency variation ; Gastroesophageal reflux ; laryngospasm ; Medical records ; Patients ; Respiration ; Respiratory function ; Saliva ; Sphincter ; Vocal cords</subject><ispartof>Muscle &amp; nerve, 2022-04, Vol.65 (4), p.400-404</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4196-c8b3dc914692a1ccbe9132d9feb67f78f842e4a5a4bf4d7da65b7bac9fb7eb023</citedby><cites>FETCH-LOGICAL-c4196-c8b3dc914692a1ccbe9132d9feb67f78f842e4a5a4bf4d7da65b7bac9fb7eb023</cites><orcidid>0000-0003-3687-8571 ; 0000-0002-7455-0254</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmus.27466$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmus.27466$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34817079$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gotesman, Ryan D.</creatorcontrib><creatorcontrib>Lalonde, Emilie</creatorcontrib><creatorcontrib>McKim, Douglas A.</creatorcontrib><creatorcontrib>Bourque, Pierre R.</creatorcontrib><creatorcontrib>Warman‐Chardon, Jodi</creatorcontrib><creatorcontrib>Zwicker, Jocelyn</creatorcontrib><creatorcontrib>Breiner, Ari</creatorcontrib><title>Laryngospasm in amyotrophic lateral sclerosis</title><title>Muscle &amp; nerve</title><addtitle>Muscle Nerve</addtitle><description>Introduction Laryngospasm is an involuntary, sustained closure of sphincter musculature that leads to an unpleasant subjective experience of dyspnea and choking. It is an underreported symptom in amyotrophic lateral sclerosis (ALS). In this study we aimed to better characterize the prevalence and clinical characteristics of laryngospasm in ALS patients. Methods The medical records of 571 patients with ALS followed between 2008 and 2018 were searched for evidence of laryngospasm. A total of 23 patients with laryngospasm were identified and the data related to patient and laryngospasm characteristics were extracted. Results Laryngospasm was reported in 4% of ALS patients. Females comprised 57% of patients and their mean age was 63.4 years. Laryngospasm frequently manifested in patients with moderate bulbar dysfunction and seemed independent of respiratory function. Among laryngospasm patients, 26% were cigarette smokers and 13% had a history of gastroesophageal reflux. The most common reported trigger was excessive saliva irritating the vocal cords (35%) followed by eating a meal (17%). There was significant variation in laryngospasm frequency (up to 5 per hour) and duration (seconds to minutes). Most patients could not identify an effective coping mechanism, although 13% reported that drinking water was effective. Discussion Despite its low prevalence in ALS, laryngospasm should be included in the symptom inquiry. The present findings may improve patient care through increased recognition of the clinical features of laryngospasm in ALS patients, identifying a link between laryngospasm and moderate bulbar dysfunction, and highlighting trigger avoidance as a management strategy. Additional research is required to understand the pathophysiology and optimal treatment. See Editorial on pages 367‐368 in this issue.</description><subject>ALS</subject><subject>Amyotrophic lateral sclerosis</subject><subject>bulbar dysfunction</subject><subject>case series</subject><subject>Cigarette smoking</subject><subject>clinical management</subject><subject>Drinking water</subject><subject>Dyspnea</subject><subject>Frequency variation</subject><subject>Gastroesophageal reflux</subject><subject>laryngospasm</subject><subject>Medical records</subject><subject>Patients</subject><subject>Respiration</subject><subject>Respiratory function</subject><subject>Saliva</subject><subject>Sphincter</subject><subject>Vocal cords</subject><issn>0148-639X</issn><issn>1097-4598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp10E1LwzAcx_EgipvTg29ACl700C1p0jwcZfgEEw868BaSNNWOpq1Ji-zdm9HpQfCUy4cv-f8AOEdwjiDMFm4I84wRSg_AFEHBUpILfgimEBGeUizeJuAkhA2EEHHKjsEEE44YZGIK0pXy2-a9DZ0KLqmaRLlt2_u2-6hMUqveelUnwdTWt6EKp-CoVHWwZ_t3BtZ3t6_Lh3T1fP-4vFmlhiBBU8M1LoxAhIpMIWO0FQhnhSitpqxkvOQks0TliuiSFKxQNNdMKyNKzayGGZ6Bq7Hb-fZzsKGXrgrG1rVqbDsEmVGIBBOY80gv_9BNO_gm_i4qLASFmOdRXY_KxDuCt6XsfOXi6RJBudtQul12t2G0F_vioJ0tfuXPaBEsRvBV1Xb7f0k-rV_G5DdonXtT</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Gotesman, Ryan D.</creator><creator>Lalonde, Emilie</creator><creator>McKim, Douglas A.</creator><creator>Bourque, Pierre R.</creator><creator>Warman‐Chardon, Jodi</creator><creator>Zwicker, Jocelyn</creator><creator>Breiner, Ari</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3687-8571</orcidid><orcidid>https://orcid.org/0000-0002-7455-0254</orcidid></search><sort><creationdate>202204</creationdate><title>Laryngospasm in amyotrophic lateral sclerosis</title><author>Gotesman, Ryan D. ; Lalonde, Emilie ; McKim, Douglas A. ; Bourque, Pierre R. ; Warman‐Chardon, Jodi ; Zwicker, Jocelyn ; Breiner, Ari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4196-c8b3dc914692a1ccbe9132d9feb67f78f842e4a5a4bf4d7da65b7bac9fb7eb023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>ALS</topic><topic>Amyotrophic lateral sclerosis</topic><topic>bulbar dysfunction</topic><topic>case series</topic><topic>Cigarette smoking</topic><topic>clinical management</topic><topic>Drinking water</topic><topic>Dyspnea</topic><topic>Frequency variation</topic><topic>Gastroesophageal reflux</topic><topic>laryngospasm</topic><topic>Medical records</topic><topic>Patients</topic><topic>Respiration</topic><topic>Respiratory function</topic><topic>Saliva</topic><topic>Sphincter</topic><topic>Vocal cords</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gotesman, Ryan D.</creatorcontrib><creatorcontrib>Lalonde, Emilie</creatorcontrib><creatorcontrib>McKim, Douglas A.</creatorcontrib><creatorcontrib>Bourque, Pierre R.</creatorcontrib><creatorcontrib>Warman‐Chardon, Jodi</creatorcontrib><creatorcontrib>Zwicker, Jocelyn</creatorcontrib><creatorcontrib>Breiner, Ari</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Muscle &amp; nerve</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gotesman, Ryan D.</au><au>Lalonde, Emilie</au><au>McKim, Douglas A.</au><au>Bourque, Pierre R.</au><au>Warman‐Chardon, Jodi</au><au>Zwicker, Jocelyn</au><au>Breiner, Ari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laryngospasm in amyotrophic lateral sclerosis</atitle><jtitle>Muscle &amp; nerve</jtitle><addtitle>Muscle Nerve</addtitle><date>2022-04</date><risdate>2022</risdate><volume>65</volume><issue>4</issue><spage>400</spage><epage>404</epage><pages>400-404</pages><issn>0148-639X</issn><eissn>1097-4598</eissn><abstract>Introduction Laryngospasm is an involuntary, sustained closure of sphincter musculature that leads to an unpleasant subjective experience of dyspnea and choking. It is an underreported symptom in amyotrophic lateral sclerosis (ALS). In this study we aimed to better characterize the prevalence and clinical characteristics of laryngospasm in ALS patients. Methods The medical records of 571 patients with ALS followed between 2008 and 2018 were searched for evidence of laryngospasm. A total of 23 patients with laryngospasm were identified and the data related to patient and laryngospasm characteristics were extracted. Results Laryngospasm was reported in 4% of ALS patients. Females comprised 57% of patients and their mean age was 63.4 years. Laryngospasm frequently manifested in patients with moderate bulbar dysfunction and seemed independent of respiratory function. Among laryngospasm patients, 26% were cigarette smokers and 13% had a history of gastroesophageal reflux. The most common reported trigger was excessive saliva irritating the vocal cords (35%) followed by eating a meal (17%). There was significant variation in laryngospasm frequency (up to 5 per hour) and duration (seconds to minutes). Most patients could not identify an effective coping mechanism, although 13% reported that drinking water was effective. Discussion Despite its low prevalence in ALS, laryngospasm should be included in the symptom inquiry. The present findings may improve patient care through increased recognition of the clinical features of laryngospasm in ALS patients, identifying a link between laryngospasm and moderate bulbar dysfunction, and highlighting trigger avoidance as a management strategy. Additional research is required to understand the pathophysiology and optimal treatment. See Editorial on pages 367‐368 in this issue.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34817079</pmid><doi>10.1002/mus.27466</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-3687-8571</orcidid><orcidid>https://orcid.org/0000-0002-7455-0254</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0148-639X
ispartof Muscle & nerve, 2022-04, Vol.65 (4), p.400-404
issn 0148-639X
1097-4598
language eng
recordid cdi_proquest_miscellaneous_2601979388
source Wiley Online Library - AutoHoldings Journals
subjects ALS
Amyotrophic lateral sclerosis
bulbar dysfunction
case series
Cigarette smoking
clinical management
Drinking water
Dyspnea
Frequency variation
Gastroesophageal reflux
laryngospasm
Medical records
Patients
Respiration
Respiratory function
Saliva
Sphincter
Vocal cords
title Laryngospasm in amyotrophic lateral sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T09%3A57%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laryngospasm%20in%20amyotrophic%20lateral%20sclerosis&rft.jtitle=Muscle%20&%20nerve&rft.au=Gotesman,%20Ryan%20D.&rft.date=2022-04&rft.volume=65&rft.issue=4&rft.spage=400&rft.epage=404&rft.pages=400-404&rft.issn=0148-639X&rft.eissn=1097-4598&rft_id=info:doi/10.1002/mus.27466&rft_dat=%3Cproquest_cross%3E2601979388%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2639960385&rft_id=info:pmid/34817079&rfr_iscdi=true